New quality check aims to reduce bleeding risks in heart patients
NCT ID NCT07354828
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well hospitals follow guidelines for blood thinner use after heart stent placement. It will enroll 3,500 patients with acute coronary syndrome who are at high risk for bleeding. Researchers will track their treatment and outcomes for 12 months to see if a new quality control system can help doctors personalize therapy and reduce complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME (ACS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
General Hospital of Northern Theater Command
Shenyang, Liaoning, 110000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict which heart blockages will worsen after stenting?
- Can a drop of blood predict disease years before it strikes?
- Can a new catheter make heart stenting safer and more effective?
- Heart rehab may tweak cell death pathways — a study investigates
- Can a trained eye match ultrasound for heart stent placement?
- Heart pump may help High-Risk patients get Life-Saving artery treatment